Data is limited on optimal co-infection testing strategies in COVID-19 and the utility of biomarkers such as C-reactive protein (CRP), white blood cell count (WBC), procalcitonin and neutrophil–lymphocyte ratio (NLR) to identify bacterial co-infections is conflicting [14–16]. This evidence concerns the gene CRP and COVID-19.